Identification |
Name: | Cefprozil |
Synonyms: | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid,7-[[(2R)-amino(4-hydroxyphenyl) acetyl]amino]-8-oxo-3-(1-propenyl)-,(6R,7R)-;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6R-(6alpha,7beta(R*)))-;Cefprozilum [INN-Latin];Cefzil (TN);Cefprozil (USP);BMY 28100;(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cronocef;Cefprozilo [INN-Spanish];CFPZ;Serozil;Brisoral;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-(1-propenyl)-, (6R,7R)-;Cefprozil anhydrous;Cefzil;(6R,7R)-7-[(2R)-2-Amino-2-(4-hydroxyphenyl) acetylamino]-8-oxo-3-(1-pro-penyl)-5-thia-1-azabicylo [4.2.0]oct-2-ene-2-carboxylic acid; |
CAS: | 92665-29-7 |
Molecular Formula: | C18H19N3O5S |
Molecular Weight: | 347.39 |
InChI: | InChI=1/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)/b3-2- |
Molecular Structure: |
|
Properties |
Transport: | 25kgs |
Density: | 1.53g/cm3 |
Appearance: | white to yellow crystalline powder |
Usage: | Semisynthetic oral cephalosporin consisting of approx. 90:10 Z/E isomeric mixture. Antibacterial |
Safety Data |
|
|